Mastering Pharmacogenomics: A Nurse's Handbook for Success

Pharmacogenomics is the study of the role of genetics in drug response and has become a vital resources in battling disease and improving outcomes. As pivotal members of the healthcare team, nurses must acquire competency in pharmacogenomics to deliver optimal patient care in the 21st century.


Type Book
CME Available No
Topic
Cost $59.95
Note

Resources are listed in paragraphs and lists

Date of Resource 2015

Genomic Competencies

Experts from the disciplines listed below have tagged this resource as fulfulling genomic competencies.

Nurse

  • Professional Responsibilities
    • PR-1:   Recognize one's own attitudes and values
      • PR1-K1:   Values, attitudes and beliefs
        • PR1-1:   Engage in reflective practice about one's own beliefs and values related to client care that integrates genetics and genomics.
        • PR1-2:   Articulate attitudes, values and beliefs that influence health care perspective about difficult genetic or genomic health care decisions.
      • PR1-K2:   Impact of personal values, attitudes and beliefs
        • PR1-1:   Engage in reflective practice about one's own beliefs and values related to client care that integrates genetics and genomics.
        • PR1-2:   Articulate attitudes, values and beliefs that influence health care perspective about difficult genetic or genomic health care decisions.
    • PR-2:   Advocate for clients' access
      • PR2-K1:   Resources for healthcare professionals and lay public
        • PR2-1:   Demonstrate appropriate care and concern for all clients throughout their referral, provision of direct care and follow-up to genetic services.
        • PR2-2:   Demonstrate knowledge about accessing local/regional genetic and/or genomic resources.
        • PR2-3:   Include genetic health care professionals in team building and collaborative strategies to optimize client outcomes.
        • PR2-4:   Help client negotiate system barriers that limit access to genetic/genomic services.
      • PR2-K2:   Resources for genetic and/or genomic referrals within one's community
        • PR2-1:   Demonstrate appropriate care and concern for all clients throughout their referral, provision of direct care and follow-up to genetic services.
        • PR2-2:   Demonstrate knowledge about accessing local/regional genetic and/or genomic resources.
        • PR2-3:   Include genetic health care professionals in team building and collaborative strategies to optimize client outcomes.
        • PR2-4:   Help client negotiate system barriers that limit access to genetic/genomic services.
    • PR-4:   Incorporate genetic and genomic technologies and information into practice.
      • PR4-K1:   Technology and information systems
        • PR4-1:   Evaluate genetic and genomic technologies used in client care.
        • PR4-2:   Demonstrate use of genetic and genomic technology and client data for clinical decision-making in providing safe client care.
        • PR4-3:   Identify the credibility, reliability and limitations of genetic and genomic information.
        • PR4-4:   Identify ethical, legal, and social issues associated with genetic/genomic information.
    • PR-5:   Demonstrate the importance of tailoring genetic and genomic information and services
      • PR5-K1:   Cultural, social, ethnic and religious perspectives
        • PR5-1:   Incorporate client's cultural, social, ethnic and religious perspective and literacy level when delivering genetic and genomic care.
        • PR5-2:   Integrate knowledge from psychology, history, politics, sociology and culture when delivering genetic and genomic care.
      • PR5-K2:   Economic and health disparities
        • PR5-1:   Incorporate client's cultural, social, ethnic and religious perspective and literacy level when delivering genetic and genomic care.
        • PR5-2:   Integrate knowledge from psychology, history, politics, sociology and culture when delivering genetic and genomic care.
  • Nursing Assessment
    • NA-1:   Demonstrate understanding of relationship of genetics and genomics to health
      • NA1-K1:   Relationship of genetics and genomics to health
        • NA1-1:   Collect a client's personal and three generation family health history to assess for genomic factors that impact the client's health.
        • NA1-2:   Identify potentially significant information from a family history.
        • NA1-3:   Identify clients who might benefit from referral to genetic specialists and/or information resources.
        • NA1-4:   Facilitate appropriate referral to genetic specialists, accurately documenting and communicating relevant history and clinical data.
        • NA1-5:   Describe a typical client journey that might be experienced in the process of genetic counseling.
        • NA1-6:   Describe genetic/genomic factors that contribute to variability of response to pharmacologic agents.
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
        • NA1-8:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
      • NA1-K2:   Relationship of genetics and genomics to normal physiology and pathophysiology
        • NA1-1:   Collect a client's personal and three generation family health history to assess for genomic factors that impact the client's health.
        • NA1-2:   Identify potentially significant information from a family history.
        • NA1-3:   Identify clients who might benefit from referral to genetic specialists and/or information resources.
        • NA1-4:   Facilitate appropriate referral to genetic specialists, accurately documenting and communicating relevant history and clinical data.
        • NA1-5:   Describe a typical client journey that might be experienced in the process of genetic counseling.
        • NA1-6:   Describe genetic/genomic factors that contribute to variability of response to pharmacologic agents.
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
        • NA1-8:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
      • NA1-K3:   Basic principles of pharmacogenetics and pharmacogenomics
        • NA1-1:   Collect a client's personal and three generation family health history to assess for genomic factors that impact the client's health.
        • NA1-2:   Identify potentially significant information from a family history.
        • NA1-3:   Identify clients who might benefit from referral to genetic specialists and/or information resources.
        • NA1-5:   Describe a typical client journey that might be experienced in the process of genetic counseling.
        • NA1-6:   Describe genetic/genomic factors that contribute to variability of response to pharmacologic agents.
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
        • NA1-8:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
      • NA1-K4:   Patterns of disease associated with single gene and multifactorial inheritance
        • NA1-1:   Collect a client's personal and three generation family health history to assess for genomic factors that impact the client's health.
        • NA1-2:   Identify potentially significant information from a family history.
        • NA1-3:   Identify clients who might benefit from referral to genetic specialists and/or information resources.
        • NA1-4:   Facilitate appropriate referral to genetic specialists, accurately documenting and communicating relevant history and clinical data.
        • NA1-5:   Describe a typical client journey that might be experienced in the process of genetic counseling.
        • NA1-6:   Describe genetic/genomic factors that contribute to variability of response to pharmacologic agents.
        • NA1-8:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
    • NA-5:   Conducts assessments incorporating genetic, environmental, and genomic influences and risk factors
      • NA5-K1:   Fundamentals of genetic and genomic focused health and physical assessment
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
      • NA5-K2:   Basics of risk factors
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
  • Identification
    • ID-1:   Identify clients who may benefit from genetic and genomic information and services
      • ID1-K1:   Components of family history needed to identify disease susceptibility or genetic/genomic condition
        • ID1-2:   Identify clients who may benefit from further evaluation of the identified disease susceptibility or genetic/genomic condition.
        • ID1-3:   Demonstrate assessment of client concerns or understanding about information received from specialty genetic services (i.e., on-line genetic testing results).
        • ID1-4:   Uses genetic and genomic indicators as rationale for clients who may benefit from further evaluation or other risk management interventions.
        • ID1-5:   Incorporate into the interprofessional plan of care the need for further genetic/genomic evaluation or other risk management interventions in collaboration with the client.
      • ID1-K2:   Inheritance patterns
        • ID1-2:   Identify clients who may benefit from further evaluation of the identified disease susceptibility or genetic/genomic condition.
        • ID1-3:   Demonstrate assessment of client concerns or understanding about information received from specialty genetic services (i.e., on-line genetic testing results).
        • ID1-4:   Uses genetic and genomic indicators as rationale for clients who may benefit from further evaluation or other risk management interventions.
        • ID1-5:   Incorporate into the interprofessional plan of care the need for further genetic/genomic evaluation or other risk management interventions in collaboration with the client.
      • ID1-K3:   Indicators of disease susceptibility or a genetic condition
        • ID1-2:   Identify clients who may benefit from further evaluation of the identified disease susceptibility or genetic/genomic condition.
        • ID1-3:   Demonstrate assessment of client concerns or understanding about information received from specialty genetic services (i.e., on-line genetic testing results).
        • ID1-4:   Uses genetic and genomic indicators as rationale for clients who may benefit from further evaluation or other risk management interventions.
        • ID1-5:   Incorporate into the interprofessional plan of care the need for further genetic/genomic evaluation or other risk management interventions in collaboration with the client.
      • ID1-K4:   Common health conditions with a genetic/genomic component
        • ID1-2:   Identify clients who may benefit from further evaluation of the identified disease susceptibility or genetic/genomic condition.
        • ID1-3:   Demonstrate assessment of client concerns or understanding about information received from specialty genetic services (i.e., on-line genetic testing results).
        • ID1-4:   Uses genetic and genomic indicators as rationale for clients who may benefit from further evaluation or other risk management interventions.
        • ID1-5:   Incorporate into the interprofessional plan of care the need for further genetic/genomic evaluation or other risk management interventions in collaboration with the client.
      • ID1-K5:   Indicators of need for targeted treatment selection
        • ID1-2:   Identify clients who may benefit from further evaluation of the identified disease susceptibility or genetic/genomic condition.
        • ID1-4:   Uses genetic and genomic indicators as rationale for clients who may benefit from further evaluation or other risk management interventions.
        • ID1-5:   Incorporate into the interprofessional plan of care the need for further genetic/genomic evaluation or other risk management interventions in collaboration with the client.
    • ID-2:   Identify credible, accurate, appropriate, and current genetic and genomic information
      • ID2-K1:   Resources for health care professionals and lay public
        • ID2-1:   Evaluate strengths, limitations, and best use of genetic and/or genomic resource for a client or group of clients.
        • ID2-2:   Discuss the ways in which nurses can meet the educational, psychosocial and resource needs of clients and families affected by a genetic or genomic condition.
        • ID2-3:   Discuss the ways in which nurses can meet the knowledge, psychosocial and resource needs of clients and families affected by genetic/genomic technology.
        • ID2-4:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • ID2-6:   Evaluate sources of evidence and clinical practice guidelines for a client whose care involves genetic and/or genomic health care. Use continuous quality improvement initiatives to update practice guidelines as necessary.
      • ID2-K2:   Resources for referral within one's community
        • ID2-1:   Evaluate strengths, limitations, and best use of genetic and/or genomic resource for a client or group of clients.
        • ID2-2:   Discuss the ways in which nurses can meet the educational, psychosocial and resource needs of clients and families affected by a genetic or genomic condition.
        • ID2-3:   Discuss the ways in which nurses can meet the knowledge, psychosocial and resource needs of clients and families affected by genetic/genomic technology.
        • ID2-4:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • ID2-6:   Evaluate sources of evidence and clinical practice guidelines for a client whose care involves genetic and/or genomic health care. Use continuous quality improvement initiatives to update practice guidelines as necessary.
      • ID2-K3:   Roles of genetic/genomic health care professionals
        • ID2-1:   Evaluate strengths, limitations, and best use of genetic and/or genomic resource for a client or group of clients.
        • ID2-2:   Discuss the ways in which nurses can meet the educational, psychosocial and resource needs of clients and families affected by a genetic or genomic condition.
        • ID2-3:   Discuss the ways in which nurses can meet the knowledge, psychosocial and resource needs of clients and families affected by genetic/genomic technology.
        • ID2-4:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • ID2-6:   Evaluate sources of evidence and clinical practice guidelines for a client whose care involves genetic and/or genomic health care. Use continuous quality improvement initiatives to update practice guidelines as necessary.
      • ID2-K4:   Interprofessional resources
        • ID2-1:   Evaluate strengths, limitations, and best use of genetic and/or genomic resource for a client or group of clients.
        • ID2-2:   Discuss the ways in which nurses can meet the educational, psychosocial and resource needs of clients and families affected by a genetic or genomic condition.
        • ID2-3:   Discuss the ways in which nurses can meet the knowledge, psychosocial and resource needs of clients and families affected by genetic/genomic technology.
        • ID2-4:   Identify resources available to assist clients seeking genetic and genomic information or services including the types of services available.
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • ID2-6:   Evaluate sources of evidence and clinical practice guidelines for a client whose care involves genetic and/or genomic health care. Use continuous quality improvement initiatives to update practice guidelines as necessary.
    • ID-3:   Identify ethical, ethnic/ancestral, cultural, religious, legal, fiscal and societal issues
      • ID3-K1:   Cultural, ethnic, family values, traditions, health beliefs and religious perspectives
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
      • ID3-K2:   The components of informed decision-making
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
      • ID3-K3:   Sources of genetic information
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
      • ID3-K4:   Capabilities and limitations of current genetic/genomic technologies
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
      • ID3-K5:   Ethical issues related to genetic/genomic information and technology
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
      • ID3-K6:   Psychosocial issues and impact of genetic/genomic information
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
      • ID3-K7:   Current state, federal, and military policies
        • ID3-1:   Demonstrate the ability to assess cultural, language, family values, traditions, health beliefs and religious perspectives that influence access to and use of genetic/genomic information, technology, and services.
        • ID3-2:   Identify cultural, language, family values, traditions, health beliefs and religious perspectives that impact access and use of genetic/genomic information, technology and services.
        • ID3-3:   Identify psychosocial issues and impact of genetic/genomic information, technology and services on individual and the family.
        • ID3-4:   Use ethical principles when deliberating genetic/genomic issues of decision-making, privacy, confidentiality, informed consent, disclosure, access, and personal impact.
        • ID3-5:   List action steps to address genetic/genomic ethical issues in practice, e.g. discuss with nursing team or supervisor, present to ethics committee.
        • ID3-6:   Describe the influence of insurance or other methods of reimbursement for services on access to genetic and genomic information and technologies.
    • ID-4:   Define issues that undermine the rights of all clients for autonomous, informed decision-making
      • ID4-K1:   Current state, federal, and military policies
        • ID4-1:   Identify respective genetic state legislation.
        • ID4-2:   Identify examples of misuse of genetic/genomic information and technology.
        • ID4-3:   Describe legal and social issues related to access and use of genetic information and technology.
        • ID4-4:   Access interprofessional ethical resources when trying to resolve ethical dilemmas.
      • ID4-K2:   The components of informed decision-making
        • ID4-1:   Identify respective genetic state legislation.
        • ID4-2:   Identify examples of misuse of genetic/genomic information and technology.
        • ID4-3:   Describe legal and social issues related to access and use of genetic information and technology.
        • ID4-4:   Access interprofessional ethical resources when trying to resolve ethical dilemmas.
      • ID4-K3:   Past and potential for misuse of genetic/genomic information and technology
        • ID4-1:   Identify respective genetic state legislation.
        • ID4-2:   Identify examples of misuse of genetic/genomic information and technology.
        • ID4-3:   Describe legal and social issues related to access and use of genetic information and technology.
        • ID4-4:   Access interprofessional ethical resources when trying to resolve ethical dilemmas.
      • ID4-K4:   Guidelines or policies regarding access
        • ID4-1:   Identify respective genetic state legislation.
        • ID4-2:   Identify examples of misuse of genetic/genomic information and technology.
        • ID4-3:   Describe legal and social issues related to access and use of genetic information and technology.
        • ID4-4:   Access interprofessional ethical resources when trying to resolve ethical dilemmas.
  • Referral activities
    • RA-1:   Facilitate referrals for specialized genetic and genomic services
      • RA1-K1:   Professional roles of providers delivering genetic and genomic services
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
      • RA1-K2:   Resources for health care professionals and lay public
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
      • RA1-K3:   Resources for genetic and genomic referrals within the community
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
  • Provision of education, care and support
    • PECS-1:   Provide clients with interpretation of genetic and genomic information
      • PECS1-K1:   Components of family history
        • PECS1-1:   Discuss factors in a family and health history that contribute to: disease susceptibility; disease characteristics, treatment, prognosis; or a genetic/genomic condition.
        • PECS1-2:   Use family history information to inform health education.
        • PECS1-3:   Discuss the role of genetic, genomic, environmental and psychosocial factors in the manifestation of disease.
        • PECS1-5:   Reinforce/clarify information provided by genetic professional to client (i.e., genetic test interpretation; informed consent).
      • PECS1-K2:   Inheritance Patterns
        • PECS1-1:   Discuss factors in a family and health history that contribute to: disease susceptibility; disease characteristics, treatment, prognosis; or a genetic/genomic condition.
        • PECS1-2:   Use family history information to inform health education.
        • PECS1-3:   Discuss the role of genetic, genomic, environmental and psychosocial factors in the manifestation of disease.
        • PECS1-5:   Reinforce/clarify information provided by genetic professional to client (i.e., genetic test interpretation; informed consent).
      • PECS1-K3:   Role of environmental and psychosocial factors
        • PECS1-1:   Discuss factors in a family and health history that contribute to: disease susceptibility; disease characteristics, treatment, prognosis; or a genetic/genomic condition.
        • PECS1-2:   Use family history information to inform health education.
        • PECS1-3:   Discuss the role of genetic, genomic, environmental and psychosocial factors in the manifestation of disease.
        • PECS1-5:   Reinforce/clarify information provided by genetic professional to client (i.e., genetic test interpretation; informed consent).
      • PECS1-K4:   Informed consent procedures and essential elements
        • PECS1-1:   Discuss factors in a family and health history that contribute to: disease susceptibility; disease characteristics, treatment, prognosis; or a genetic/genomic condition.
        • PECS1-2:   Use family history information to inform health education.
        • PECS1-3:   Discuss the role of genetic, genomic, environmental and psychosocial factors in the manifestation of disease.
        • PECS1-5:   Reinforce/clarify information provided by genetic professional to client (i.e., genetic test interpretation; informed consent).
    • PECS-2:   Provide clients with genetic and genomic information and resources for informed decision making
      • PECS2-K1:   Resources for healthcare professionals and lay public
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • PECS2-1:   Evaluate strengths, limitations, and best use of one genetic and/or genomic resource for a client or group of clients.
        • PECS2-2:   Help clients interpret and understand genetic and genomic information.
      • PECS2-K2:   Referral resources for genetic and genomic services within one's community
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • PECS2-1:   Evaluate strengths, limitations, and best use of one genetic and/or genomic resource for a client or group of clients.
        • PECS2-2:   Help clients interpret and understand genetic and genomic information.
      • PECS2-K3:   Roles of genetic/genomic health care professionals
        • ID2-5:   Develop a list of contacts and resources for genetic/genomic referrals.
        • PECS2-1:   Evaluate strengths, limitations, and best use of one genetic and/or genomic resource for a client or group of clients.
        • PECS2-2:   Help clients interpret and understand genetic and genomic information.
    • PECS-3a:   Use health promotion/disease prevention practices that consider genetic and genomic influences
      • PECS3-K1:   Role of environmental and psychosocial factors
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
      • PECS3-K2:   Fundamentals of epidemiology and biostatistics
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
      • PECS3-K3:   Ongoing research contributing to improved understanding of the genetic/genomic influences on health
        • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
    • PECS-3b:   Use health promotion/disease prevention practices incorporating knowledge of genetic and/or genomic risk factors
      • NA1-7:   Incorporate genetic and genomic health assessment data into routinely collected biopsychosocial and environmental assessments of health and illness parameters in client, using culturally sensitive approaches.
    • PECS-4:   Use genetic- and genomic-based interventions and information to improve clients' outcomes
      • PECS4-K1:   Pharmacogenetics, pharmacogenomics
        • PECS4-1:   Demonstrate ability to incorporate family history as part of the nursing assessment.
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
      • PECS4-K2:   Gene or gene product targeted therapy
        • PECS4-1:   Demonstrate ability to incorporate family history as part of the nursing assessment.
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
      • PECS4-K3:   Protein replacement therapy
        • PECS4-1:   Demonstrate ability to incorporate family history as part of the nursing assessment.
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
      • PECS4-K4:   Chaperone therapy
        • PECS4-1:   Demonstrate ability to incorporate family history as part of the nursing assessment.
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
    • PECS-5:   Collaborate with health care providers to provide genetic and genomic health care in health promotion/disease prevention
      • PECS5-K1:   Roles of genetic/genomic health care professionals
        • PECS5-1:   Use interprofessional communication and collaboration skills to deliver safe, evidence-based, client-centered care.
        • PECS5-2:   Demonstrate team building and collaborative strategies when working with interprofessional teams.
        • PECS5-3:   Adopt a range of interpersonal skills whilst communicating with clients and colleagues about genetic/genomic issues.
      • PECS5-K2:   Roles of other genetic/genomic specialists
        • PECS5-1:   Use interprofessional communication and collaboration skills to deliver safe, evidence-based, client-centered care.
        • PECS5-2:   Demonstrate team building and collaborative strategies when working with interprofessional teams.
        • PECS5-3:   Adopt a range of interpersonal skills whilst communicating with clients and colleagues about genetic/genomic issues.
    • PECS-7:   Performs interventions/treatments appropriate to clients' genetic and genomic healthcare needs.
      • PECS7-K1:   Pharmacogenetics, pharmacogenomics
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
        • PECS7-1:   Administer medications safely with consideration of pharmacogenetic test results if available.
        • PECS7-2:   Administer prescribed genetic / genomic based therapies safely as allowed per State Practice Act.
        • PECS7-3:   Teach client about purpose, expected benefits, limitations and potential risks of genetic/genomic based interventions.
      • PECS7-K2:   Gene or gene product targeted therapy
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
        • PECS7-1:   Administer medications safely with consideration of pharmacogenetic test results if available.
        • PECS7-2:   Administer prescribed genetic / genomic based therapies safely as allowed per State Practice Act.
        • PECS7-3:   Teach client about purpose, expected benefits, limitations and potential risks of genetic/genomic based interventions.
      • PECS7-K3:   Protein replacement therapy
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS4-3:   Intervene when client has an unintended response to genetic/genomic based interventions to ensure client safety.
        • PECS7-1:   Administer medications safely with consideration of pharmacogenetic test results if available.
        • PECS7-2:   Administer prescribed genetic / genomic based therapies safely as allowed per State Practice Act.
        • PECS7-3:   Teach client about purpose, expected benefits, limitations and potential risks of genetic/genomic based interventions.
      • PECS7-K4:   Chaperone therapy
        • PECS4-2:   Monitor client response to genetic/genomic based interventions.
        • PECS7-1:   Administer medications safely with consideration of pharmacogenetic test results if available.
        • PECS7-2:   Administer prescribed genetic / genomic based therapies safely as allowed per State Practice Act.
        • PECS7-3:   Teach client about purpose, expected benefits, limitations and potential risks of genetic/genomic based interventions.
    • PECS-8:   Evaluate impact and effectiveness of technology, information, interventions, and treatments
      • PECS8-K1:   Range of psychosocial responses
        • PECS8-1:   Assess client response to genetic/genomic information.
        • PECS8-2:   Assess client response to genetic/genomic based interventions.
        • PECS8-3:   Assess client response to genetic/genomic services.
        • PECS8-4:   Use evaluation of genetic/genomic technology, information and interventions to modify client's plan of care.
      • PECS8-K2:   Expected outcomes of various genetic/genomic based interventions
        • PECS8-1:   Assess client response to genetic/genomic information.
        • PECS8-2:   Assess client response to genetic/genomic based interventions.
        • PECS8-3:   Assess client response to genetic/genomic services.
        • PECS8-4:   Use evaluation of genetic/genomic technology, information and interventions to modify client's plan of care.